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Background: Evidence is mixed regarding the effects of
hematopoietic cell transplantation (HCT) on changes in
cognitive functioning among adults. Meta-analysis may help
reconcile conﬂicting ﬁndings but has not yet been conducted
with this literature. The current study provides a systematic
review and meta-analysis of cognitive functioning in adults
receiving HCT.
Methods: A search of PubMed, PsycInfo, CINAHL, and
Cochrane Library yielded 732 abstracts, which were inde-
pendently evaluated and selected for inclusion by pairs of
raters. Original studies of neuropsychological functioning in
HCT recipients who were adults at the time of transplant
were included in the systematic review (k¼17). A subset of
studies assessing patients pre- and post-transplant and
providing adequate data to calculate effect sizes was
included in the meta-analysis (k¼11).
Results: The systematic review found consensus that
a subset of patients experience cognitive impairment prior to
HCT. Evidence was conﬂicting about whether cognitive
functioning improved, declined, or remained stable at
follow-up. Meta-analytic ﬁndings of 404 patients indicated
no signiﬁcant changes in cognitive functioning pre- to post-
HCT (ps>.05). Age, time since transplant, and total body
irradiation were not associated with changes in cognitive
functioning. Patients who received autologous transplants
were more likely to demonstrate improvements in attention
(p¼.004), however.
Conclusions: Results of the current study suggest that on
average, patients who are experiencing cognitive difﬁculties
prior to HCT are unlikely to demonstrate signiﬁcant improve-
ment post-transplant, with the exception of improved atten-
tion in autologous HCT recipients. The failure of HCT patients
to demonstrate improvements over repeated tests may itself
be a sign of a deﬁcit, as improvement due to test familiarity
would be expected. Patients reporting cognitive difﬁculties
that interfere with daily functioning should be referred to
a neuropsychologist for evaluation and management.205
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Background: Quality of life is increasingly recognized as one
of patients’ primary concerns and an important clinical
endpoint of hematopoietic cell transplant (HCT). Although
a growing body of research has examined change in quality
of life during the transplant process, the extent to which
these data have been incorporated into patient education is
unclear. The goal of the current study was to examine
education regarding post-HCT quality of life from the
patient's perspective.
Methods:Men andwomenwho had received allogeneic HCT
two to four years previously participated in one of four
qualitative focus groups based on a semi-structured inter-
view guide. Participants were asked to recall what they had
been told about post-HCT quality of life as they were
deciding to undergo the transplant, how their current quality
of life differed from what they expected, and how to best
educate future HCT recipients about quality of life. Verbatimtranscripts were coded for a priori and emergent themes
using content analysis.
Results: A total of 24 patients participated (54% female,
mean age 51, range 23-73). Regarding patient education,
most participants noted that they had been told about
potential side effects of HCT and behavioral and dietary
restrictions, but little about quality of life. Many reported
actively trying to avoid information about HCT pre-trans-
plant and instead focused on surviving the procedure.
Participants often reported that their post-HCT quality of life
ﬂuctuated, which was contrary to their expectations
regarding sustained improvement. Participants widely
agreed that patient education regarding quality of life should
occur throughout the transplant process. They emphasized
that the ability to control the amount of information was
important, as was hearing about quality of life from other
patients.
Conclusions: These data suggest that patient education
regarding post-HCT quality of life could be improved.
Educational materials that are tailored to patients’ informa-
tion preferences, can be used throughout transplant and
survivorship, and feature other HCT recipients are preferred.206
The Effect of Exercise Compliance in Patients Undergoing
Hematopoietic Stem Cell Transplantation on Their
Functional Capacity During Their Hospitalization
Gomati Kanphade, Paula Rexer. Physical Medicine &
Rehabilitation, University of Michigan Health System,
Ann Arbor, MI
Purpose/Hypothesis: To examine the impact of an in-patient
exercise program of participants undergoing hematopoietic
stem cell transplant (HSCT) on functional capacity, and to
compare the relationship between exercise compliance and
incidence of exercise-related adverse events. The goals are
1) to examine the feasibility of tracking outcomes of an
exercise program in patients undergoing HSCT on their
functional capacity, and 2) to examine the association
between exercise compliance and exercise-related effects in
patients with severe pancytopeniawithin this patient cohort.
Materials/Methods: 30 adult participants were recruited
during their inpatient hospital stay. Participants completed
the short form Physical Activity Questionnaire (PAQ), 6-
minute walk test and 5-times-repeated-sit-to-stand test at
time of transplant and 12-14 days post-transplant. Partici-
pants instructed in a multimodal intervention to include
aerobic (walking or stationary bike), resistance (resistance
bands), and active range of motion exercises. Exercise
compliance was measured by the patient's exercise log.
Incidence of hemorrhagic events and platelet levels were
collected. This research consisted of a one group pre-test/
post-test study design with consecutive sampling over an
estimated nine month span (recruitment to be ﬁnished by
October 2012). Descriptive statistics will be used to describe
functional capacity trends from pre and post-test measure-
ments, to examine patient's functional capacity from start
and end of study. This study will be utilizing a post hoc
analysis to further investigate compliance and differences on
functional capacity measures by subgroups. Will also deter-
mine the relationship of the incidence of exercise-related
pancytopenia events over 14 days and percent exercise
compliance rate, controlling for confounding factors.
Results: We anticipate that participants performing the
prescribed exercise program will have improved functional
capacity. We expect no difference with higher exercise
compliant participants in incidence of hemorrhagic events as
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Conclusions: By undertaking this study we will ﬁnd out
whether there is preliminary support for the effectiveness of
the currently used in-hospital exercise program for people
who are undergoing HSCT with various levels of pancyto-
penia. We will also determine whether higher compliance
with an exercise program is associated with better functional
outcomes.
Clinical Relevance: Since there are few studies supporting
patient exercising or performing functional activities with
acute pancytopenia, we hope to lay some groundwork in this
area for further research into this and other similar patient
populations.207
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Allogeneic hematopoietic cell transplantation (AHCT)
remains an arduous medical therapy that challenges the
physical and psychological reserves of the family unit at
all stages of the process. Few studies have focused on the
perspectives of healthy siblings regarding the types of
support needed as they journey across the AHCT trajec-
tory. This IRB-approved qualitative study explored the
minor/young adult siblings’ experiences of the AHSCT
experience, speciﬁcally the types of support they would
recommend to other siblings going through this experi-
ence. A retrospective interview approach was used to
capture the perspectives of 12 siblings of successful
pediatric matched sibling donor transplants at our insti-
tution between January 1999 and September 2009. All 12
participants had been HLA tested, with 8 serving as
matched sibling donors. Median age at the time of the
AHCT was 12 years (yrs) (range, 2-23 yrs) and at the time
of the interview was 16 yrs (range, 10-30 yrs). The median
time between donation and the interview was 6 yrs
(range, 2-10 yrs). A grounded theory approach was used
to analyze and interpret transcribed interview data. Semi-
structured private interviews, demographic data, and ﬁeld
notes were the primary sources of data. Seven themes
emerged: (a) being included in the health care “family”,
(b) being involved with the ill sibling, (c) being prepared
for each step of the process, (d) meeting others who have
been through the experience, (e) receiving reassurance
and hope, (f) drawing on the support of parents/family
after the procedure, and (g) talking to others about their
experiences. The stories of these participants supported
that the ill sibling, the family, and the health care team all
play an important role in supporting them across the
transplant trajectory. Interventions must be designed to
focus on the unique physical, emotional and social needs
of siblings to help them make sense of the transplant
process. Age-appropriate educational materials will
provide youth with accurate information as well as a way
to help them ask questions and express emotions. Finally,
providing professional support that extends beyond the
transplant itself is essential for helping them piece
together the meaning of the transplant and related events
for their lives.208
Development of a Pediatric HSCT Multi-Disciplinary
Survivor Clinic
Lisa McDonald 1, Julie Luke 1, Taylor Fletcher 2, Robert Sanders 1,
Veronica H. Jude 1, Ka Wah Chan 1. 1 Pediatric Blood and
Marrow Stem Cell Transplant, Texas Transplant Institute,
San Antonio, TX; 2 Oklahoma State University
Pediatric cancer survivorship is a growing subspecialty
however few clinicians focus solely on survivors of hema-
topoietic stem cell transplant (HSCT). There were 100,000
HSCT survivors in the US in 2009 and an estimated 250,000
survivors by 2020 (CIBMTR data). Approximately 80% of
pediatric HSCT patients survive at least two years post
transplant and are expected to become long term survivors.
Post-transplant complications are the third cause of death in
this patient population. The focus of clinical management
then shifts toward decreasing the morbidity of long-term
treatment effects through early detection and intervention.
We piloted a multi-disciplinary pediatric HSCT survivor
clinic. From more than 400 patients transplanted at our
center between 2003 and 2011, 32 patients were seen at one
of 5 long-term follow-up clinic days in July and August 2012.
Eligible patients were at least one year post HSCT and off
immune suppression, and were invited based on availability.
Fourteen patients were male, 18 female. Average age at time
of transplant was 6.7 years (0.1-17 years); average age at time
of survivor clinic was 10.7 years (range 2-20 years). Most
were greater than 4 years post HSCT (range 17-117 months)
and had undergone allogeneic HSCT. The most common late
effects detected were musculoskeletal (59%, primarily
vitamin D deﬁciency and bone mineral loss), and endocrine
(56%). Cardiac late effects were seen in 2 patients and were
not life threatening (1 hypertension and 1 hyperlipidemia).
Pulmonary late effects were seen in 9% of patients, derma-
tologic in 12%, psychological in 18% and 44% were catego-
rized as other, mostly low vaccine titers. No second
malignancies were identiﬁed. School performance concerns
were common (n¼ 40%).
More than 40 referrals were generated to other pediatric
specialists as a result of our evaluation. A comprehensive
cancer summary with speciﬁc recommendations from the
multi-disciplinary team was mailed to each patient and
appropriate medical providers.
Late effects in the growing population of HSCT survivors
are common and, thus create an obligation to screen, apply
early interventions, and refer to appropriate specialists as
part of their post-transplant care.
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Background: With improved survival following pediatric
stem cell transplantation (SCT), long term effects of the
therapy including OP and ON need to be addressed. These
problems are known to occur in adult solid organ trans-
plantation and adult SCT but little is reported in the pediatric
literature. High-risk features associated with diminished
bone density include hypothyroidism, hypogonadism,
